Amarin to Present at Two Upcoming Investor Conferences
November 11 2021 - 07:00AM
Amarin Corporation plc (NASDAQ:AMRN) today announced that Karim
Mikhail, president and chief executive officer of Amarin, and
Michael Kalb, chief financial officer of Amarin, are scheduled to
participate in the following upcoming investor conferences:
Jefferies 2021 London Healthcare
Conference
Date/Time: November 16, 2021 at 1:40 pm GMT
(8:40 am ET)Format: Corporate PresentationPresenter: Karim
Mikhail
Piper Sandler
33rd Annual Virtual Healthcare
Conference
Date/Time: Available On-Demand starting November
22, 2021 for registered attendeesFormat: Fireside ChatPresenter:
Karim Mikhail
Live audio webcasts of the discussions will be
available under Events in the Investor Relations section of the
Company’s website at
https://investor.amarincorp.com/events-and-presentations/events.
About AmarinAmarin is an
innovative pharmaceutical company leading a new paradigm in
cardiovascular disease management. From our foundation in
scientific research to our focus on clinical trials, and now our
commercial expansion, we are evolving and growing rapidly. Amarin
has offices in Bridgewater, New Jersey in the United States, Dublin
in Ireland, Zug in Switzerland, and other countries in Europe as
well as commercial partners and suppliers around the world. We are
committed to increasing the scientific understanding of the
cardiovascular risk that persists beyond traditional therapies and
advancing the treatment of that risk.
Availability of Other Information About
Amarin Amarin communicates with its investors and the
public using the company website (www.amarincorp.com) and the
investor relations website (investor.amarincorp.com), including but
not limited to investor presentations and FAQs, Securities and
Exchange Commission filings, press releases, public conference
calls and webcasts. The information that Amarin posts on these
channels and websites could be deemed to be material information.
As a result, Amarin encourages investors, the media and others
interested in Amarin to review the information that is posted on
these channels, including the investor relations website, on a
regular basis. This list of channels may be updated from time to
time on Amarin’s investor relations website and may include social
media channels. The contents of Amarin’s website or these channels,
or any other website that may be accessed from its website or these
channels, shall not be deemed incorporated by reference in any
filing under the Securities Act of 1933. Amarin Contact
InformationInvestor Inquiries:Investor RelationsAmarin
Corporation plcIn U.S.: +1 (908)
719-1315IR@amarincorp.com (investor inquiries)
Solebury TroutIn U.S.: +1 (646)
378-2992amarinir@troutgroup.com
Media Inquiries:CommunicationsAmarin Corporation
plcIn U.S.: +1 (908) 892-2028PR@amarincorp.com (media
inquiries)
Amarin (NASDAQ:AMRN)
Historical Stock Chart
From Feb 2024 to Mar 2024
Amarin (NASDAQ:AMRN)
Historical Stock Chart
From Mar 2023 to Mar 2024